Chlorpromazine hydrochloride 25 MG Oral Tablet

INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance.

amneal pharmaceuticals ny llc

FDA Reported Adverse Reactions
`[1] diarrhoea` `[2] nausea` `[3] off label use` `[4] drug ineffective` `[5] vomiting` `[6] fatigue` `[7] dyspnoea` `[8] pyrexia` `[9] pain` `[10] asthenia`

4 years ago

ROUND WHITE B2

HOW SUPPLIED

CHLORPROMAZINE HYDROCHLORIDE Tablets USP, 10 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B” with black ink on one side and plain on the other side. They are available as follows: Bottles of 100: NDC 69238-1054-1

CHLORPROMAZINE HYDROCHLORIDE Tablets USP, 25 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B2” with black ink on one side and plain on the other side. They are available as follows: Bottles of 100: NDC 69238-1056-1

CHLORPROMAZINE HYDROCHLORIDE Tablets USP, 50 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B3” with black ink on one side and plain on the other side. They are available as follows: Bottles of 100: NDC 69238-1058-1 THESE TABLET STRENGTHS LISTED BELOW ARE FOR USE ONLY IN SEVERE NEUROPSYCHIATRIC CONDITIONS.

CHLORPROMAZINE HYDROCHLORIDE Tablets USP, 100 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B4” with black ink on one side and plain on the other side. They are available as follows: Bottles of 100: NDC 69238-1060-1

CHLORPROMAZINE HYDROCHLORIDE Tablets USP, 200 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B5” with black ink on one side and plain on the other side. They are available as follows: Bottles of 100: NDC 69238-1062-1 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture. This package is not for household dispensing. If dispensed for outpatient use, a well closed, light-resistant, child-resistant container should be utilized. Keep out of reach of children. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Oral Solid Dosage Unit Ahmedabad 382213, INDIA Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 12-2019-01

More pills like ROUND B2

Related Pills

chlorpromazine hydrochloride 100 mg oral tablet

amneal pharmaceuticals ny llc

Chlorpromazine hydrochloride 200 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

Chlorpromazine hydrochloride 50 MG Oral Tablet

amneal pharmaceuticals ny llc

Chlorpromazine hydrochloride 100 MG Oral Tablet

amneal pharmaceuticals ny llc

buspirone hydrochloride 10 MG Oral Tablet

Mylan Institutional Inc.

potassium chloride tablet extended release

amneal pharmaceuticals ny llc

buspirone hydrochloride 10 MG Oral Tablet

Mylan Institutional Inc.

Ibuprofen 200 MG Oral Capsule

Bionpharma Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site